H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 7.8% of adults in Washington have diagnosed diabetes — 4.2 points below the U.S. 12% figure. Census population 689,545. District of Columbia Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Washington clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Washington storefront.
Fibrin Matrix Therapy Products in Washington, DC for clinics & physicians. Fibrin matrix therapy supports… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of fibrin matrix therapy in Washington: (1) CDC PLACES (2023, crude) estimates 7.8% of adults in Washington have diagnosed diabetes — 4.2 points below the U.S. 12% figure. (2) District of Columbia Part B wound biologics are reviewed by Novitas Solutions under JL, shared with DE, MD, NJ, PA. We help with the second file. We do not pretend to be a Washington storefront.
National Fibrin Matrix Therapy Products notes (how the product actually works)Three grains, kept separate on purpose. City: Census 689,545 and CDC PLACES crude rates. State: DC Health, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and Novitas Solutions LCDs. CDC PLACES (2023, crude) estimates 7.8% of adults in Washington have diagnosed diabetes — 4.2 points below the U.S. 12% figure.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 7.8% of adults in Washington have diagnosed diabetes — 4.2 points below the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the fibrin matrix therapy account.
CDC PLACES (2023, crude prevalence) estimates 7.8% of adults — 4.2 points below the U.S. 12% figure. Obesity is 24.6%; arthritis is 16.9%. That is place-level BRFSS modeling, not a clinic census and not a Washington trial.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in Washington.
District of Columbia is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
We do not publish a consumer directory of every account. Patients should ask their current specialist whether the practice offers fibrin matrix therapy products and which products they use.
Bring specialty, monthly wound volume, and whether you bill JL FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 7.8% diabetes and 16.9% arthritis for Washington — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Washington, DC.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Washington is JL geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Washington — 4.2 points below the U.S. 12% figure. Planning input, not an outcomes claim.
District of Columbia Part B wound biologics follow this contractor (siblings: DE, MD, NJ, PA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Washington. Useful for joint-program math; still needs a diagnosis and privileging.
No Washington storefront. Joe Bradley is an active practice owner. fibrin matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.